86 related articles for article (PubMed ID: 2979800)
1. Multidisciplinary evaluation of rat renal cell carcinoma.
Karthaus HF; Feitz WF; vd Meijden AP; Schalken JA; Beck JL; Hendriks BT; Jap PH; Vooijs GP; Debruyne FM; Ramaekers FC
In Vivo; 1987; 1(6):335-41. PubMed ID: 2979800
[TBL] [Abstract][Full Text] [Related]
2. Multiparameter analysis of four human renal cell carcinoma xenografts in nude mice.
Karthaus HF; Feitz WF; Ramaekers FC; Beck JL; Hendriks BT; Schalken JA; Kurth KH; Jap PH; Debruyne FM
In Vivo; 1987; 1(6):327-34. PubMed ID: 2485135
[TBL] [Abstract][Full Text] [Related]
3. Establishment and characterization of two divergent cell lines derived from a human chromophobe renal cell carcinoma.
Gerharz CD; Moll R; Störkel S; Ramp U; Hildebrandt B; Molsberger G; Koldovsky P; Gabbert HE
Am J Pathol; 1995 Apr; 146(4):953-62. PubMed ID: 7717462
[TBL] [Abstract][Full Text] [Related]
4. Renal cell carcinoma in the Wistar-Lewis rat: a model for studying the mechanisms of cholesterol acquisition by a tumor in vivo.
Clayman RV; Bilhartz LE; Buja LM; Spady DK; Dietschy JM
Cancer Res; 1986 Jun; 46(6):2958-63. PubMed ID: 3486039
[TBL] [Abstract][Full Text] [Related]
5. Establishment and characterization of five new human renal tumor xenografts.
Beniers AJ; Peelen WP; Schaafsma HE; Beck JL; Ramaekers FC; Debruyne FM; Schalken JA
Am J Pathol; 1992 Feb; 140(2):483-95. PubMed ID: 1739137
[TBL] [Abstract][Full Text] [Related]
6. [Immunohistochemical analysis of 42 renal cell carcinomas and one oncocytoma with mono- and polyclonal antibodies against vimentin and cytokeratin].
Beham A; Ratschek M; Zatloukal K; Denk H; Lackinger E
Verh Dtsch Ges Pathol; 1989; 73():392-5. PubMed ID: 2482624
[TBL] [Abstract][Full Text] [Related]
7. Characterization of two cell lines with distinct phenotypes and genotypes established from a patient with renal cell carcinoma.
Hashimura T; Tubbs RR; Connelly R; Caulfield MJ; Trindade CS; McMahon JT; Galetti TP; Edinger M; Sandberg AA; Dal Cin P
Cancer Res; 1989 Dec; 49(24 Pt 1):7064-71. PubMed ID: 2582448
[TBL] [Abstract][Full Text] [Related]
8. [Identification of prognostic parameters for renal cell carcinoma by cDNA arrays and cell chips].
Moch H; Schraml P; Bubendorf L; Mirlacher M; Kononen J; Gasser T; Mihatsch MJ; Kallioniemi OP; Sauter G
Verh Dtsch Ges Pathol; 1999; 83():225-32. PubMed ID: 10714215
[TBL] [Abstract][Full Text] [Related]
9. Ultrastructural appearance and cytoskeletal architecture of the clear, chromophilic, and chromophobe types of human renal cell carcinoma in vitro.
Gerharz CD; Moll R; Störkel S; Ramp U; Thoenes W; Gabbert HE
Am J Pathol; 1993 Mar; 142(3):851-9. PubMed ID: 7681259
[TBL] [Abstract][Full Text] [Related]
10. Changes in gene expression during chemical-induced nephrocarcinogenicity in the Eker rat.
Patel SK; Ma N; Monks TJ; Lau SS
Mol Carcinog; 2003 Nov; 38(3):141-54. PubMed ID: 14587099
[TBL] [Abstract][Full Text] [Related]
11. Decreased expression of the human stem cell marker, Rex-1 (zfp-42), in renal cell carcinoma.
Raman JD; Mongan NP; Liu L; Tickoo SK; Nanus DM; Scherr DS; Gudas LJ
Carcinogenesis; 2006 Mar; 27(3):499-507. PubMed ID: 16344273
[TBL] [Abstract][Full Text] [Related]
12. DNA content in renal cell carcinoma. A clinical study with special reference to tumor heterogeneity and prognosis.
Ljungberg B
Scand J Urol Nephrol Suppl; 1986; 100():1-47. PubMed ID: 3472340
[TBL] [Abstract][Full Text] [Related]
13. Flow cytometric analysis of DNA-aneuploidy subgroups and proliferation in renal cell carcinoma.
Schafhauser W; Liedl T; Elsässer D; Zörcher T; Schrott KM
Anticancer Res; 1999; 19(2C):1471-5. PubMed ID: 10365126
[TBL] [Abstract][Full Text] [Related]
14. Cell proliferation in renal cell carcinoma. A clinical study with special reference to prognosis.
Larsson P
Scand J Urol Nephrol Suppl; 1994; 165():1-48. PubMed ID: 7871395
[TBL] [Abstract][Full Text] [Related]
15. Novel mitochondrial DNA deletion found in a renal cell carcinoma.
Horton TM; Petros JA; Heddi A; Shoffner J; Kaufman AE; Graham SD; Gramlich T; Wallace DC
Genes Chromosomes Cancer; 1996 Feb; 15(2):95-101. PubMed ID: 8834172
[TBL] [Abstract][Full Text] [Related]
16. Proliferating cell nuclear antigen (PCNA), immunostaining and flow cytometric DNA analysis of renal cell carcinoma.
Tanioka F; Hiroi M; Yamane T; Hara H
Zentralbl Pathol; 1993 Aug; 139(3):185-93. PubMed ID: 8105885
[TBL] [Abstract][Full Text] [Related]
17. Heterogeneity of DNA index in renal-cell carcinoma.
Devonec M; Bringuier PP; Hijazi A; Dutrieux-Berger N; Revillard JP; Perrin P
Prog Clin Biol Res; 1990; 348():35-48. PubMed ID: 2385607
[No Abstract] [Full Text] [Related]
18. Chromophobe renal cell carcinoma: a comparative study of histological, immunohistochemical and ultrastructural features using high throughput tissue microarray.
Abrahams NA; MacLennan GT; Khoury JD; Ormsby AH; Tamboli P; Doglioni C; Schumacher B; Tickoo SK
Histopathology; 2004 Dec; 45(6):593-602. PubMed ID: 15569050
[TBL] [Abstract][Full Text] [Related]
19. Renal collecting (Bellini) duct carcinoma displays similar characteristics to upper tract urothelial cell carcinoma.
Orsola A; Trias I; Raventós CX; Español I; Cecchini L; Orsola I
Urology; 2005 Jan; 65(1):49-54. PubMed ID: 15667862
[TBL] [Abstract][Full Text] [Related]
20. PCR-based RFLP screening of the commonly deleted 3p loci in renal cortical neoplasms.
el-Naggar AK; Batsakis JG; Wang G; Lee MS
Diagn Mol Pathol; 1993 Dec; 2(4):269-76. PubMed ID: 7906993
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
